Anne Große-Wilde

1.4k total citations
14 papers, 1.0k citations indexed

About

Anne Große-Wilde is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Anne Große-Wilde has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Anne Große-Wilde's work include Cell death mechanisms and regulation (5 papers), interferon and immune responses (3 papers) and Cancer Cells and Metastasis (2 papers). Anne Große-Wilde is often cited by papers focused on Cell death mechanisms and regulation (5 papers), interferon and immune responses (3 papers) and Cancer Cells and Metastasis (2 papers). Anne Große-Wilde collaborates with scholars based in United States, Germany and United Kingdom. Anne Große-Wilde's co-authors include Henning Walczak, Aymeric Fouquier d’Hérouël, Antonio del Sol, Sui Huang, Rolf Kuestner, Gökhan Ertaylan, Alexander Skupin, Kathie‐Anne Walters, Martin R. Sprick and Heiko Stahl and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Anne Große-Wilde

13 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Große-Wilde United States 11 608 390 253 236 120 14 1.0k
Laurent Pouyet France 15 810 1.3× 313 0.8× 225 0.9× 321 1.4× 72 0.6× 18 1.4k
Travis W. Bainbridge United States 15 773 1.3× 702 1.8× 194 0.8× 320 1.4× 119 1.0× 23 1.6k
Venugopalan Cheriyath United States 20 868 1.4× 211 0.5× 165 0.7× 364 1.5× 110 0.9× 29 1.3k
Maureen Spit Netherlands 11 878 1.4× 487 1.2× 162 0.6× 136 0.6× 179 1.5× 13 1.3k
Sharon Biton Israel 12 1.3k 2.1× 385 1.0× 361 1.4× 192 0.8× 123 1.0× 13 1.5k
Chul‐Woong Chung South Korea 12 829 1.4× 306 0.8× 112 0.4× 159 0.7× 74 0.6× 20 1.1k
Wendy Dubois United States 21 1.1k 1.8× 328 0.8× 201 0.8× 372 1.6× 99 0.8× 35 1.6k
Pavel Moudrý Czechia 14 957 1.6× 512 1.3× 209 0.8× 125 0.5× 72 0.6× 18 1.3k
Patrice Lassus France 13 965 1.6× 420 1.1× 172 0.7× 191 0.8× 71 0.6× 22 1.3k
Takeharu Sakamoto Japan 22 587 1.0× 307 0.8× 566 2.2× 235 1.0× 62 0.5× 54 1.2k

Countries citing papers authored by Anne Große-Wilde

Since Specialization
Citations

This map shows the geographic impact of Anne Große-Wilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Große-Wilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Große-Wilde more than expected).

Fields of papers citing papers by Anne Große-Wilde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Große-Wilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Große-Wilde. The network helps show where Anne Große-Wilde may publish in the future.

Co-authorship network of co-authors of Anne Große-Wilde

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Große-Wilde. A scholar is included among the top collaborators of Anne Große-Wilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Große-Wilde. Anne Große-Wilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mahalingam, Devalingam, Stefan N. Symeonides, Maria J. de Miguel, et al.. (2024). 699 Updated safety, PK/PD, and efficacy results from the dose escalation part of a phase I clinical trial of BNT411, a systemic Toll-like receptor 7 agonist, in patients with advanced solid tumors. Regular and Young Investigator Award Abstracts. A801–A801.
2.
Pusztai, Lajos, Hailing Lu, Anne Große-Wilde, et al.. (2020). 323 Systemic administration of ladiratuzumab vedotin alone or in combination with pembrolizumab results in significant immune activation in the tumor microenvironment in metastatic breast cancer patients. Regular and Young Investigator Award Abstracts. A198–A199. 3 indexed citations
3.
Große-Wilde, Anne, Rolf Kuestner, Aymeric Fouquier d’Hérouël, et al.. (2018). Loss of inter-cellular cooperation by complete epithelial-mesenchymal transition supports favorable outcomes in basal breast cancer patients. Oncotarget. 9(28). 20018–20033. 15 indexed citations
4.
Specht, Jennifer M., Lajos Pusztai, Andres Forero‐Torres, et al.. (2018). Post-treatment biopsies show evidence of cell cycle arrest and immune cell infiltration into tumors of ladiratuzumab vedotin-treated advanced breast cancer patients. Annals of Oncology. 29. viii92–viii92. 2 indexed citations
5.
Große-Wilde, Anne, Aymeric Fouquier d’Hérouël, Gökhan Ertaylan, et al.. (2015). Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival. PLoS ONE. 10(5). e0126522–e0126522. 277 indexed citations
6.
Große-Wilde, Anne, Oksana Voloshanenko, S. Lawrence Bailey, et al.. (2008). TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. Journal of Clinical Investigation. 118(1). 100–110. 152 indexed citations
7.
Herzer, Kerstin, Anne Große-Wilde, Peter H. Krammer, Peter R. Galle, & Stephan Kanzler. (2008). Transforming Growth Factor-β–Mediated Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression and Apoptosis in Hepatoma Cells Requires Functional Cooperation between Smad Proteins and Activator Protein-1. Molecular Cancer Research. 6(7). 1169–1177. 20 indexed citations
8.
Große-Wilde, Anne & Christopher J. Kemp. (2008). Metastasis Suppressor Function of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand-R in Mice: Implications for TRAIL-Based Therapy in Humans?. Cancer Research. 68(15). 6035–6037. 20 indexed citations
9.
Herzer, Kerstin, Tom M. Ganten, Henning Schulze‐Bergkamen, et al.. (2005). Transforming Growth Factor β Can Mediate Apoptosis Via the Expression of TRAIL in Human Hepatoma Cells *. Hepatology. 42(1). 183–192. 23 indexed citations
10.
Ganten, Tom M., Tobias L. Haas, J Sýkora, et al.. (2004). Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death and Differentiation. 11(S1). S86–S96. 176 indexed citations
11.
Weigand, Markus A., Anne Große-Wilde, Markus Janke, et al.. (2003). TNF-Related Apoptosis-Inducing Ligand Mediates Tumoricidal Activity of Human Monocytes Stimulated by Newcastle Disease Virus. The Journal of Immunology. 170(4). 1814–1821. 93 indexed citations
12.
Große-Wilde, Anne, Angelika Hoffmeyer, Bruce W.M. Jordan, et al.. (2000). Serine/Threonine Kinases 3pK and MAPK-activated Protein Kinase 2 Interact with the Basic Helix-Loop-Helix Transcription Factor E47 and Repress Its Transcriptional Activity. Journal of Biological Chemistry. 275(27). 20239–20242. 55 indexed citations
13.
Hoffmeyer, Angelika, Anne Große-Wilde, Egbert Flory, et al.. (1999). Different Mitogen-activated Protein Kinase Signaling Pathways Cooperate to Regulate Tumor Necrosis Factor α Gene Expression in T Lymphocytes. Journal of Biological Chemistry. 274(7). 4319–4327. 91 indexed citations
14.
Dittrich, Falk, G. Ochs, Anne Große-Wilde, et al.. (1996). Pharmacokinetics of Intrathecally Applied BDNF and Effects on Spinal Motoneurons. Experimental Neurology. 141(2). 225–239. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Pouyet Breakdown of academic impact, for papers by Travis W. Bainbridge Breakdown of academic impact, for papers by Venugopalan Cheriyath Breakdown of academic impact, for papers by Maureen Spit Breakdown of academic impact, for papers by Sharon Biton Breakdown of academic impact, for papers by Chul‐Woong Chung Breakdown of academic impact, for papers by Wendy Dubois Breakdown of academic impact, for papers by Pavel Moudrý Breakdown of academic impact, for papers by Patrice Lassus Breakdown of academic impact, for papers by Takeharu Sakamoto
Rankless by CCL
2026